[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 68
Citations 0
Editor's Correspondence
Apr 23, 2012

Coronary Artery Calcium Scanning and Conflicts of Interest

Author Affiliations

Author Affiliation: Department of Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, Massachusetts.

Arch Intern Med. 2012;172(8):670-670. doi:10.1001/archinternmed.2012.276

Coronary artery calcium (CAC) score and high-sensitivity C-reactive protein level are currently the leading contenders to join traditional risk factors in routine clinical assessment of coronary heart disease risk. I do not believe that there is sufficient data to use either at present, and I read with interest the thoughtful critique of CAC scanning by Ridker.1 No conflicts of interest are reported, but Ridker is a co-inventor on patents held by Brigham and Women's Hospital that use high-sensitivity C-reactive protein in assessing cardiovascular disease risk. Having a financial stake in a competitor of CAC scanning for coronary artery disease risk stratification is an important conflict of interest to share with readers.

First Page Preview View Large
First page PDF preview
First page PDF preview